Cali Fund to Face Debate at COP17 Summit in Armenia
Nations will discuss how to monetize digital genetic data to protect global biodiversity amid low corporate participation.
Updated on Oct. 16, 2026 in Biotech
Live Poll
Should companies pay for using genetic data from nature to help fund global biodiversity protection?
At the upcoming COP17 biodiversity summit in Armenia, running October 19 to 30, 2026, nations will debate the future of the voluntary Cali Fund. The mechanism aims to monetize the use of digital DNA sequences for global conservation, though participation remains minimal.
Why it matters
The fund seeks to bridge the gap between commercial research and biodiversity preservation, yet companies currently avoid it because voluntary payments do not grant legal immunity from national access and benefit-sharing laws. This friction hampers a system projected to capture significant annual revenue.
The Cali Fund invites approximately 22,000 eligible companies to contribute 1 percent of annual profits or 0.1 percent of revenues. While the model targets massive scale, only two companies have contributed to date.
The players
Cali Fund
A multilateral financial mechanism designed to distribute benefits derived from digital genetic information for global nature conservation.
Convention on Biological Diversity
The 1992 international treaty that serves as the legal framework for global environmental and genetic resource governance.
The details
Companies utilize Digital Sequence Information, where they sequence DNA and upload the resulting data into online repositories to facilitate research and development. The Cali Fund is designed to channel a portion of the commercial value derived from this data back into global biodiversity protection efforts. Currently, the system functions as a voluntary multilateral mechanism, but its efficacy is limited by the existence of 65 countries with their own distinct national access and benefit-sharing (ABS) legislation.
Timeline
1992: Convention on Biological Diversity treaty established.
2014: Nagoya Protocol on access and benefit-sharing signed.
2022: Countries agreed to establish a new benefit-sharing system.
October 19-30, 2026: COP17 biodiversity summit occurs in Armenia.
The Tech Race
The Cali Fund seeks to modernize the principles of the 2014 Nagoya Protocol to account for the rise of digital genetic sequence data. It competes against a fragmented landscape where 65 nations maintain their own individual legal requirements for accessing genetic resources.
Companies in the biotech and pharmaceutical sectors face increasing pressure to adopt this new funding model to standardize their research costs. Until a unified legal framework replaces the current patchwork of national laws, businesses will likely remain cautious about voluntary contributions.
The takeaway
The struggle to fund global biodiversity through corporate contributions highlights the difficulty of applying centralized treaties to digital research. Watch for new compliance guidelines emerging from the October 2026 summit that may finally bridge the gap between voluntary funding and mandatory legal safety.
Further reading
Explore deeper into the intersection of genetic data and policy at /tech/biotech/.
Source note: This article includes information reported by Eco-Business.
Live Poll
Should companies pay for using genetic data from nature to help fund global biodiversity protection?
